158
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The Translation, Reliability and Validity of the Chinese Version of the Hill–Bone Compliance to High Blood Pressure Therapy Scale in Adults with Hypertension

ORCID Icon, , , , &
Pages 1853-1860 | Published online: 09 Oct 2020

References

  • Barrera L. High blood pressure prevention and control: from evidence to action. Colomb Med. 2018;49(2):137–138.
  • Patel P, Ordunez P, DiPette D, et al. Improved blood pressure control to reduce cardiovascular disease morbidity and mortality: the standardized hypertension treatment and prevention project. J Clin Hypertens (Greenwich). 2016;18(12):1284–1294. doi:10.1111/jch.12861
  • Grassi G, Quarti F, Mancia G. Hypertension, antihypertensive treatment and stroke prevention. Neurol Sci. 2005;26(Suppl 1):S22–S23.
  • Aronow WS. Hypertension-related stroke prevention in the elderly. Curr Hypertens Rep. 2013;15(6):582–589. doi:10.1007/s11906-013-0384-x
  • Hamrahian SM, Falkner B. Hypertension in chronic kidney disease. Adv Exp Med Biol. 2017;956:307–325.
  • Pugh D, Gallacher PJ, Dhaun N. Management of hypertension in chronic kidney disease. Drugs. 2019;79(4):365–379. doi:10.1007/s40265-019-1064-1
  • Gavrilova A, Bandere D, Rutkovska I, et al. Knowledge about disease, medication therapy, and related medication adherence levels among patients with hypertension. Medicina (Kaunas, Lithuania). 2019;55(11).
  • Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–237. doi:10.1038/s41581-019-0244-2
  • Zhou Y, Jia L, Lu B, et al. Updated hypertension prevalence, awareness, and control rates based on the 2017ACC/AHA high blood pressure guideline. J Clin Hyperten. 2019;21(6):758–765.
  • Yang Q, Chang A, Ritchey MD, Loustalot F. Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort study. J Am Heart Assoc. 2017;6(6). doi:10.1161/JAHA.117.006056
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
  • Shehab A, Elnour AA, Swaidi SA, et al. Evaluation and implementation of behavioral and educational tools that improves the patients’ intentional and unintentional non-adherence to cardiovascular medications in family medicine clinics. Saudi Pharm J. 2016;24(2):182–188. doi:10.1016/j.jsps.2015.02.022
  • Akhu-Zaheya LM, Shiyab WY. The effect of short message system (SMS) reminder on adherence to a healthy diet, medication, and cessation of smoking among adult patients with cardiovascular diseases. Int J Med Inform. 2017;98:65–75. doi:10.1016/j.ijmedinf.2016.12.003
  • Christensen A, Osterberg LG, Hansen EH. Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review. J Hypertens. 2009;27(8):1540–1551. doi:10.1097/HJH.0b013e32832d50ef
  • Hou MY, Hurwitz S, Kavanagh E, Fortin J, Goldberg AB. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet Gynecol. 2010;116(3):633–640. doi:10.1097/AOG.0b013e3181eb6b0f
  • Piette JD, Datwani H, Gaudioso S, et al. Hypertension management using mobile technology and home blood pressure monitoring: results of a randomized trial in two low/middle-income countries. Telemed e-Health. 2012;18(8):613–620. doi:10.1089/tmj.2011.0271
  • Mudhune V, Gvetadze R, Girde S, et al. Correlation of adherence by pill count, self-report, MEMS and plasma drug levels to treatment response among women receiving ARV therapy for PMTCT in Kenya. AIDS Behav. 2018;22(3):918–928. doi:10.1007/s10461-017-1724-7
  • Sandbaumhüter FA, Haschke M, Vogt B, Bohlender JM. Indexed plasma drug concentrations for drug adherence screening in hypertensive patients. Ann Cardiol Angeiol. 2018;67(3):119–126. doi:10.1016/j.ancard.2018.04.020
  • He W, Bonner A, Anderson D. Patient reported adherence to hypertension treatment: A revalidation study. Eur J Cardiovasc Nurs. 2016;15(2):150–156. doi:10.1177/1474515115603902
  • Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hyperten. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
  • Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15(3):90–96. doi:10.1111/j.1751-7117.2000.tb00211.x
  • Lomper K, Chabowski M, Chudiak A, Białoszewski A, Dudek K, Jankowska-Polańska B. Psychometric evaluation of the polish version of the adherence to refills and medications scale (ARMS) in adults with hypertension. Patient Prefer Adherence. 2018;12:2661–2670. doi:10.2147/PPA.S185305
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
  • Uchmanowicz I, Jankowska-Polańska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the polish adaptation of the Hill-Bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16:87. doi:10.1186/s12872-016-0270-y
  • Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15(4):207–211. doi:10.3109/13814780903452150
  • Song Y, Han HR, Song HJ, Nam S, Nguyen T, Kim MT. Psychometric evaluation of hill-bone medication adherence subscale. Asian Nurs Res (Korean Soc Nurs Sci). 2011;5(3):183–188. doi:10.1016/j.anr.2011.09.007
  • Efstathiou G. Translation, adaptation and validation process of research instruments. Individualized Care. 2019;2019:65–78.
  • Anthoine E, Moret L, Regnault A, Sébille V, Hardouin JB. Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes. 2014;12:176. doi:10.1186/s12955-014-0176-2
  • Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297–334. doi:10.1007/BF02310555
  • Bujang MA, Omar ED, Baharum NA. A review on sample size determination for cronbach’s alpha test: a simple guide for researchers. Malays J Med Sci. 2018;25(6):85–99. doi:10.21315/mjms2018.25.6.9
  • Streiner D, Norman G,Cairney J. Health Measurement Scales: A practical Guide to Their Development and use. 5th ed. Oxford University Press; 2015. Available from: https://oxfordmedicine.com/view/10.1093/med/9780199685219.001.0001/med-978019968521. Accessed September 29, 2020.
  • Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63(3):299–306. doi:10.1016/j.jclinepi.2009.06.011
  • Cheong AT, Tong SF, Sazlina SG. Validity and reliability of the Malay version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary healthcare settings in Malaysia: a cross-sectional study. Malays Fam Physician. 2015;10(2):36–44.
  • Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330(3):128–133. doi:10.1097/00000441-200509000-00006
  • Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One. 2013;8(4):e62775. doi:10.1371/journal.pone.0062775
  • Pan J, Wu L, Wang H, et al. Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients. Medicine. 2019;98(27):e16116.